Are platinum-based chemotherapeutic drugs safe for patients with Charcot-Marie-Tooth disease?
Yerushalmi
Ronit
R
Levi
Itay
I
Wygoda
Marc
M
Ifergane
Gal
G
Wirguin
Itzhak
I
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018236:Carcinoma, Embryonal / Q000188:drug therapy; D002607:Charcot-Marie-Tooth Disease / Q000139:chemically induced* / Q000473:pathology; D002945:Cisplatin / Q000009:adverse effects*; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D013736:Testicular Neoplasms / Q000188:drug therapy; D014750:Vincristine / Q000009:adverse effects*
D000970:Antineoplastic Agents; D014750:Vincristine; D002945:Cisplatin